Literature DB >> 15689246

An alternative non-invasive treatment for Peyronie's disease.

Joaquim A Claro1, Carlo C Passerotti, Antonio C Figueiredo Neto, Archimedes Nardozza, Valdemar Ortiz, Miguel Srougi.   

Abstract

OBJECTIVE: Surgical correction of the deformity and plaque caused by Peyronie's disease has some important disadvantages and extracorporeal shockwave therapy (ESWT) emerged as a new promising therapy. We evaluated prospectively the efficacy and safety of the association of high dose vitamin E and ESWT as a non-invasive treatment for the disease.
MATERIALS AND METHODS: Twenty-five patients 42 to 68 years old (mean = 54) presenting penile deviation and sexual distress caused by Peyronie's disease were treated in a non-invasive manner. The time of penile deviation ranged from 16 to 52 months (mean = 30). All patients had previous unsuccessful treatment for Peyronie's disease. The angulation's deformity of the penis was assessed by photography at home. The patients received vitamin E (l.200 mg daily) during 3 months and underwent 3 to 6 sessions (mean = 3) of ESWT (3,000 to 4,000 shockwaves) at a power level of l to 2 at 1-week intervals.
RESULTS: From 25 patients treated, 16 (64%) reported an improvement in penile angulation, with a mean reduction of 21 degrees (10 to 40). Eight patients reported improvement in their spontaneous erections. Overall, the patients presented only minimal bruising at the site of treatment and skin hematoma. Four patients presented urethral bleeding. The mean angulation after treatment in the control group was 48.67 degrees (30 - 70) and in the study group was 24.42 degrees (0 - 70), statistically significant.
CONCLUSION: Considering the common complications and the unsatisfactory outcome of the surgical correction for Peyronie's disease, the association of high dose vitamin E and ESWT represents a good option for a non-invasive, effective and safe treatment of the penile deformity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15689246     DOI: 10.1590/s1677-55382004000300004

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  9 in total

1.  PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.

Authors:  Aylin N Bilgutay; Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2015-06-01

2.  Laser Therapy for Peyronie's Disease: A Randomized Control Double-Blind Pilot Study.

Authors:  Farzad Allameh; Mohammadreza Razzaghi; Seyed Mansoor Rayegani; Morteza Fallah-Karkan; Arash Ranjbar; Amirhosein Rahavian; Atefeh Javadi; Saleh Ghiasy; Zahra Razzaghi
Journal:  J Lasers Med Sci       Date:  2019-12-01

Review 3.  Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain.

Authors:  Grzegorz Lukasz Fojecki; Stefan Tiessen; Palle Jörn Sloth Osther
Journal:  World J Urol       Date:  2016-04-23       Impact factor: 4.226

Review 4.  Conservative Therapy for Peyronie's Disease: a Contemporary Review of the Literature.

Authors:  Ayad Yousif; Caleb Natale; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2021-01-08       Impact factor: 3.092

Review 5.  Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough?

Authors:  Mikkel Fode; Georgios Hatzichristodoulou; Ege Can Serefoglu; Paolo Verze; Maarten Albersen
Journal:  Nat Rev Urol       Date:  2017-07-25       Impact factor: 14.432

6.  Non-conventional therapies for Peyronie's disease: what is the evidence for efficacy?

Authors:  Ishan Aditya; Jethro C C Kwong; Yonah Krakowsky; Ethan D Grober
Journal:  Transl Androl Urol       Date:  2020-03

7.  Pro: does shockwave therapy have a place in the treatment of Peyronie's disease?

Authors:  Eric Chung
Journal:  Transl Androl Urol       Date:  2016-06

Review 8.  Peyronie's disease: What's around the bend?

Authors:  Aylin N Bilgutay; Alexander W Pastuszak
Journal:  Indian J Urol       Date:  2016 Jan-Mar

Review 9.  Peyronie's disease and low intensity shock wave therapy: Clinical outcomes and patient satisfaction rate in an open-label single arm prospective study in Australian men.

Authors:  Eric Chung
Journal:  Korean J Urol       Date:  2015-11-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.